Acadia Pharmaceuticals | DŁUG





DŁUG Zmiana Data
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
ALKERMES USD 72.68M 293.32M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Biogen USD 6.29B 309.5M 2025-09
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Corcept Therapeutics USD 6.6M 2.03M 2025-06
Cytokinetics USD 858.06M 199.93M 2025-06
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Incyte USD 42.41M 5.29M 2025-06
J&J USD 45.8B 4.97B 2025-09
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.85B 78M 2025-09
Prothena USD 9.08M 699K 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Acadia Pharmaceuticals DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.